Ivermectin and filariasis.

Area of Science:

• Medical Parasitology
• Public Health
• Tropical Medicine

Background:

• Ivermectin, initially a veterinary parasiticide, emerged as a key intervention for human filarial diseases in the 1980s.
• Its efficacy against microfilariae and favorable safety profile are well-established.
• The World Health Organization (WHO) identified it as a critical component for disease eradication programs.

Purpose of the Study:

• To highlight the significance of Ivermectin in the global control of filarial diseases.
• To underscore its role in the WHO's initiatives for eradicating onchocerciasis and lymphatic filariasis.
• To emphasize the public health impact of a cost-effective, single-dose annual treatment.

Main Methods:

• Review of Ivermectin's historical application in veterinary and human medicine.
• Analysis of its pharmacological properties, including efficacy against microfilariae and safety.
• Examination of WHO's strategic use of Ivermectin in mass drug administration programs.

Main Results:

• Ivermectin demonstrated high effectiveness in blocking the transmission of filarial diseases.
• Annual administration as a single oral dose proved to be a practical and well-tolerated treatment strategy.
• These attributes facilitated the WHO's declaration of onchocerciasis and lymphatic filariasis as eradicable.

Conclusions:

• Ivermectin is an indispensable tool for the control and potential eradication of major human filarial diseases.
• Its cost-effectiveness, ease of administration, and safety profile make it a cornerstone of global health initiatives.
• The successful implementation of Ivermectin treatment has paved the way for eliminating significant endemic diseases worldwide.